Copyright Reports & Markets. All rights reserved.

Point of Care Molecular Diagnostics -Global Market Status and Trend Report 2013-2023

Request for Sample of this report
Buy now

Table of Contents

    Chapter 1 Overview of Point of Care Molecular Diagnostics

    • 1.1 Definition of Point of Care Molecular Diagnostics in This Report
    • 1.2 Commercial Types of Point of Care Molecular Diagnostics
      • 1.2.1 Assays and Kits
      • 1.2.2 Instruments or Analyzers
      • 1.2.3 Services and Software
    • 1.3 Downstream Application of Point of Care Molecular Diagnostics
      • 1.3.1 Respiratory Diseases
      • 1.3.2 Sexually Transmitted Diseases
      • 1.3.3 Hospital-acquired Infection
      • 1.3.4 Oncology
      • 1.3.5 Hepatitis
      • 1.3.6 Others
    • 1.4 Development History of Point of Care Molecular Diagnostics
    • 1.5 Market Status and Trend of Point of Care Molecular Diagnostics 2013-2023
      • 1.5.1 Global Point of Care Molecular Diagnostics Market Status and Trend 2013-2023
      • 1.5.2 Regional Point of Care Molecular Diagnostics Market Status and Trend 2013-2023

    Chapter 2 Global Market Status and Forecast by Regions

    • 2.1 Market Development of Point of Care Molecular Diagnostics 2013-2017
    • 2.2 Production Market of Point of Care Molecular Diagnostics by Regions
      • 2.2.1 Production Volume of Point of Care Molecular Diagnostics by Regions
      • 2.2.2 Production Value of Point of Care Molecular Diagnostics by Regions
    • 2.3 Demand Market of Point of Care Molecular Diagnostics by Regions
    • 2.4 Production and Demand Status of Point of Care Molecular Diagnostics by Regions
      • 2.4.1 Production and Demand Status of Point of Care Molecular Diagnostics by Regions 2013-2017
      • 2.4.2 Import and Export Status of Point of Care Molecular Diagnostics by Regions 2013-2017

    Chapter 3 Global Market Status and Forecast by Types

    • 3.1 Production Volume of Point of Care Molecular Diagnostics by Types
    • 3.2 Production Value of Point of Care Molecular Diagnostics by Types
    • 3.3 Market Forecast of Point of Care Molecular Diagnostics by Types

    Chapter 4 Global Market Status and Forecast by Downstream Industry

    • 4.1 Demand Volume of Point of Care Molecular Diagnostics by Downstream Industry
    • 4.2 Market Forecast of Point of Care Molecular Diagnostics by Downstream Industry

    Chapter 5 Market Driving Factor Analysis of Point of Care Molecular Diagnostics

    • 5.1 Global Economy Situation and Trend Overview
    • 5.2 Point of Care Molecular Diagnostics Downstream Industry Situation and Trend Overview

    Chapter 6 Point of Care Molecular Diagnostics Market Competition Status by Major Manufacturers

    • 6.1 Production Volume of Point of Care Molecular Diagnostics by Major Manufacturers
    • 6.2 Production Value of Point of Care Molecular Diagnostics by Major Manufacturers
    • 6.3 Basic Information of Point of Care Molecular Diagnostics by Major Manufacturers
      • 6.3.1 Headquarters Location and Established Time of Point of Care Molecular Diagnostics Major Manufacturer
      • 6.3.2 Employees and Revenue Level of Point of Care Molecular Diagnostics Major Manufacturer
    • 6.4 Market Competition News and Trend
      • 6.4.1 Merger, Consolidation or Acquisition News
      • 6.4.2 Investment or Disinvestment News
      • 6.4.3 New Product Development and Launch

    Chapter 7 Point of Care Molecular Diagnostics Major Manufacturers Introduction and Market Data

    • 7.1 Myriad Genetics
      • 7.1.1 Company profile
      • 7.1.2 Representative Point of Care Molecular Diagnostics Product
      • 7.1.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Myriad Genetics
    • 7.2 Cepheid
      • 7.2.1 Company profile
      • 7.2.2 Representative Point of Care Molecular Diagnostics Product
      • 7.2.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Cepheid
    • 7.3 Illumina Inc.
      • 7.3.1 Company profile
      • 7.3.2 Representative Point of Care Molecular Diagnostics Product
      • 7.3.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Illumina Inc.
    • 7.4 Abbott
      • 7.4.1 Company profile
      • 7.4.2 Representative Point of Care Molecular Diagnostics Product
      • 7.4.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abbott
    • 7.5 Agilent Technologies Inc.
      • 7.5.1 Company profile
      • 7.5.2 Representative Point of Care Molecular Diagnostics Product
      • 7.5.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Agilent Technologies Inc.
    • 7.6 Hoffmann-La Roche Ltd.
      • 7.6.1 Company profile
      • 7.6.2 Representative Point of Care Molecular Diagnostics Product
      • 7.6.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Hoffmann-La Roche Ltd.
    • 7.7 GenePOC Inc.
      • 7.7.1 Company profile
      • 7.7.2 Representative Point of Care Molecular Diagnostics Product
      • 7.7.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of GenePOC Inc.
    • 7.8 QIAGEN
      • 7.8.1 Company profile
      • 7.8.2 Representative Point of Care Molecular Diagnostics Product
      • 7.8.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN
    • 7.9 Hologic Inc.
      • 7.9.1 Company profile
      • 7.9.2 Representative Point of Care Molecular Diagnostics Product
      • 7.9.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Hologic Inc.
    • 7.10 Genomic Health
      • 7.10.1 Company profile
      • 7.10.2 Representative Point of Care Molecular Diagnostics Product
      • 7.10.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Genomic Health
    • 7.11 Beckman Coulter Inc
      • 7.11.1 Company profile
      • 7.11.2 Representative Point of Care Molecular Diagnostics Product
      • 7.11.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Beckman Coulter Inc
    • 7.12 Siemens Healthcare GmbH
      • 7.12.1 Company profile
      • 7.12.2 Representative Point of Care Molecular Diagnostics Product
      • 7.12.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Siemens Healthcare GmbH
    • 7.13 DxNA LLC.
      • 7.13.1 Company profile
      • 7.13.2 Representative Point of Care Molecular Diagnostics Product
      • 7.13.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of DxNA LLC.
    • 7.14 Abaxis, Bayer AG,
      • 7.14.1 Company profile
      • 7.14.2 Representative Point of Care Molecular Diagnostics Product
      • 7.14.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abaxis, Bayer AG,
    • 7.15 Johnson & Johnson Services Inc.
      • 7.15.1 Company profile
      • 7.15.2 Representative Point of Care Molecular Diagnostics Product
      • 7.15.3 Point of Care Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Johnson & Johnson Services Inc.
    • 7.16 Biocartis
    • 7.17 Binx Health Inc.
    • 7.18 Grifols S.A.
    • 7.19 Medtronic
    • 7.20 Spartan Bioscience Inc.
    • 7.21 Quidel Corporation
    • 7.22 bioMérieux SA
    • 7.23 Sysmex Corporation
    • 7.24 BD
    • 7.25 OraSure Technologies Inc.
    • 7.26 Bio-Rad Laboratories Inc.
    • 7.27 Meridian Bioscience Inc.
    • 7.28 Danaher

    Chapter 8 Upstream and Downstream Market Analysis of Point of Care Molecular Diagnostics

    • 8.1 Industry Chain of Point of Care Molecular Diagnostics
    • 8.2 Upstream Market and Representative Companies Analysis
    • 8.3 Downstream Market and Representative Companies Analysis

    Chapter 9 Cost and Gross Margin Analysis of Point of Care Molecular Diagnostics

    • 9.1 Cost Structure Analysis of Point of Care Molecular Diagnostics
    • 9.2 Raw Materials Cost Analysis of Point of Care Molecular Diagnostics
    • 9.3 Labor Cost Analysis of Point of Care Molecular Diagnostics
    • 9.4 Manufacturing Expenses Analysis of Point of Care Molecular Diagnostics

    Chapter 10 Marketing Status Analysis of Point of Care Molecular Diagnostics

    • 10.1 Marketing Channel
      • 10.1.1 Direct Marketing
      • 10.1.2 Indirect Marketing
      • 10.1.3 Marketing Channel Development Trend
    • 10.2 Market Positioning
      • 10.2.1 Pricing Strategy
      • 10.2.2 Brand Strategy
      • 10.2.3 Target Client
    • 10.3 Distributors/Traders List

    Chapter 11 Report Conclusion

      Chapter 12 Research Methodology and Reference

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources

      Report Summary

      Point of Care Molecular Diagnostics -Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Point of Care Molecular Diagnostics  industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

      Worldwide and Regional Market Size of Point of Care Molecular Diagnostics  2013-2017, and development forecast 2018-2023
      Main manufacturers/suppliers of Point of Care Molecular Diagnostics  worldwide, with company and product introduction, position in the Point of Care Molecular Diagnostics  market
      Market status and development trend of Point of Care Molecular Diagnostics  by types and applications
      Cost and profit status of Point of Care Molecular Diagnostics , and marketing status
      Market growth drivers and challenges

      The report segments the global Point of Care Molecular Diagnostics  market as:

      Global Point of Care Molecular Diagnostics  Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
      North America
      Europe
      China
      Japan
      Rest APAC
      Latin America

      Global Point of Care Molecular Diagnostics  Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
      Assays and Kits
      Instruments or Analyzers
      Services and Software

      Global Point of Care Molecular Diagnostics  Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
      Respiratory Diseases
      Sexually Transmitted Diseases
      Hospital-acquired Infection
      Oncology
      Hepatitis
      Others

      Global Point of Care Molecular Diagnostics  Market: Manufacturers Segment Analysis (Company and Product introduction, Point of Care Molecular Diagnostics  Sales Volume, Revenue, Price and Gross Margin):
      Myriad Genetics
      Cepheid
      Illumina Inc.
      Abbott
      Agilent Technologies Inc.
      Hoffmann-La Roche Ltd.
      GenePOC Inc.
      QIAGEN
      Hologic Inc.
      Genomic Health
      Beckman Coulter Inc
      Siemens Healthcare GmbH
      DxNA LLC.
      Abaxis, Bayer AG,
      Johnson & Johnson Services Inc.
      Biocartis
      Binx Health Inc.
      Grifols S.A.
      Medtronic
      Spartan Bioscience Inc.
      Quidel Corporation
      bioMérieux SA
      Sysmex Corporation
      BD
      OraSure Technologies Inc.
      Bio-Rad Laboratories Inc.
      Meridian Bioscience Inc.
      Danaher

      In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
      Buy now